Skip to main content

Table 1 Patient characteristics

From: Study of inter- and intra-observer reproducibility in the interpretation of [18F]choline PET/CT examinations in patients suffering from biochemically recurrent prostate cancer following curative treatment

Characteristics Value
Age (years)  
 Average 71
 Min to max 57 to 86
 Median 72
Initial PSA level (ng/ml)  
 Average 14.77
 Min to max 1.5 to 63
 Median 9.80
PSA level; at the time of the PET/CT request (ng/ml)  
 Average 6.43
 Min to max 0.35 to 154
 Median 2.73
Gleason score  
 ≤7 56
 >7 4
 NA 5
TNM Stage  
 Any T2Nx 2
 Any T2N0M0 18
 Any T2N1M0 1
 Any T1c N0 or Nx 15
 Any T3N0M0 8
 Any T3N1 5
 Any T3Nx 3
 NA 8
Initial treatment  
 Surg. Only 9
 Surg. A nd RT 8
 Surg. RT and HT 2
 RT only 34
 Brachytherapy only 5
Time to double PSA (months)  
 >12 months 6
 = 12 months 8
 <12 months 5
 <6 months 4
 ≤3 months 5
 NA 32
Velocity (ng/ml/year)  
 Average 2.87
 Min to max 0.05 to 15.45
 Median 2.03
  1. PSA, prostatic specific antigen; TNM, tumor nodes metastasis; RT, radiotherapy; HT, hormone therapy.